DNA Sequencing and Next-Generation Sequencing Market Overview, Growth, Trends, Demand, Types, Technology, Industry Analysis and Forecasts Research Report 2029

PUNE, MAHARASHTRA, INDIA, June 28, 2022 /EINPresswire.com/ -- A worldwide DNA Sequencing and Next-Generation Sequencing marketing document identifies, analyses, and estimates the up-and-coming trends along with major drivers, challenges and opportunities in the industry. Further, analysis of vendors, geographical regions, types, and applications has been carried out here. Taking up such market report is always beneficial for businesses when it is about sound decision making and superior management of goods and services. The report is presented with full commitment and best possible service depending upon business requirements. The leading DNA Sequencing and Next-Generation Sequencing market analysis report acts as a great source of information with which businesses can get a telescopic view of the existing market trends, consumer’s demands and preferences, market situations, opportunities, and market status.

While creating DNA Sequencing and Next-Generation Sequencing market research report, the key attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. A numerous markets, marketing strategies, trends, future products and rising opportunities have been considered while studying market for preparing this report. This business report has been formed with the vigilant efforts of innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. Have the business at the highest level of growth with an all-inclusive DNA Sequencing and Next-Generation Sequencing market document.

Data Bridge Market Research analyses that the DNA sequencing and next-generation sequencing market which was USD 13.82 billion in 2021, would rocket up to USD 50.04 billion by 2029, and is expected to undergo a CAGR of 17.45% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Sample Copy of the Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dna-sequencing-and-next-generation-sequencing-market

Market Definition

High-throughput sequencing is another name for next-generation sequencing. NGS allows for fast base pair sequencing of DNA samples. NGS is advancing drug development and paving the way for future personalized medicine, genetic illnesses, and clinical diagnostics. Furthermore, next-generation sequencing (NGS) is a massively parallel sequencing method capable of determining the order of nucleotides in a full genome with scalability, ultra-high throughput, and rapid speed.

Some of the major players operating in the DNA sequencing and next-generation sequencing market are:

Illumina Inc. (U.S)
Thermo Fischer Scientific Inc. (U.S)
Oxford Nanopore Technologies plc (U.K)
Agilent Technologies, Inc. (U.S)
BGI (China)
PerkinElmer Inc. (U.S)
QIAGEN (Germany)
Eurofins Scientific (Luxembourg)
F. Hoffmann-La Roche Ltd (Switzerland)
Takara Bio Inc. (Japan)
GENEWIZ, Inc. (U.S)
Hamilton Company (U.S)
Macrogen Inc. (South Korea)
Zymo Research Corporation(U.S)
Tecan Trading AG (Switzerland) 

Drivers

Increasing number of cancer cases

The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall growth of the DNA next generation sequencing industry.

Rising R&D activities for developing novel next generation sequencing technologies

Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of genetic disorders among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

Increasing advantages of next generation sequencing techniques

In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue.

Opportunities

The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the DNA next generation sequencing industry.

COVID-19 impact on DNA Sequencing and Next-Generation Sequencing Market

The COVID-19 epidemic had a huge influence on the world as a whole, causing economic collapse and death. It has resulted in a worldwide pandemic that is extremely transmissible. With the advancement of technology, next-generation sequencing is becoming increasingly important in a variety of fields. From manufacturing PPE kits to inventing test kits to detect the virus and vaccines to prevent transmission, a number of pharmaceutical businesses and agencies have contributed to reducing the infection's impact. To combat the virus, businesses have strengthened their R&D and production workforce. Because of the increasing benefit of determining and finding the genetic sequence of a virus, which helps scientists to comprehend the virus's entire mutation, the overall influence on the next generation sequencing industry and market is expected to be beneficial. Hundreds of coronaviruses and SARS-CoV-2 genomes which were determined with NGS are publicly available for researchers to study the origin of COVID-19.

Access Full Report: https://www.databridgemarketresearch.com/reports/global-dna-sequencing-and-next-generation-sequencing-market

Recent Development

In December 2020, Eurofins Genomics has released SARS-CoV-2 NGS services that are both cost-effective and optimised, allowing for entire viral genome sequencing.
In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.

DNA Sequencing and Next-Generation Sequencing Market Scope

Product

Instruments
Consumables
Services

Type

Whole genome sequencing
Exome sequencing
Targeted sequencing
Others

Application

Research application
Clinical application
Others

Technology

Sequencing by synthesis
Ion semiconductor sequencing
Others

End-user

Academic institutes and research centers
Hospitals and clinics
Pharmaceutical and biotechnology companies
Others

Table of Contents:  DNA Sequencing and Next-Generation Sequencing Market

1 Introduction

2 Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Covid-19 Impact on DNA Sequencing and Next-Generation Sequencing in Healthcare Industry

7 DNA Sequencing and Next-Generation Sequencing Market, by Product Type

8 DNA Sequencing and Next-Generation Sequencing Market, by Modality

9 DNA Sequencing and Next-Generation Sequencing Market, by Type

10 DNA Sequencing and Next-Generation Sequencing Market, by Mode

11 DNA Sequencing and Next-Generation Sequencing Market, by End User

12 DNA Sequencing and Next-Generation Sequencing Market, by Geography

13 DNA Sequencing and Next-Generation Sequencing Market, Company Landscape

14 Swot Analysis

15 Company Profiles

16 Questionnaire

17 Related Reports

Get Table of Content: https://www.databridgemarketresearch.com/toc/?dbmr=global-dna-sequencing-and-next-generation-sequencing-market

This study answers to the below key questions:

1 What will the market size be in 2029?

2 What are the key factors driving the DNA Sequencing and Next-Generation Sequencing Market?

3 What are the challenges to market growth?    

4 Who are the key players in the DNA Sequencing and Next-Generation Sequencing Market?

5 What are the market opportunities and threats faced by the key players?

Related Report:

Global Bone Wax Market By Product (Absorbable Bone Wax, Non-absorbable Bone Wax), Material (Natural Bone Wax, Synthetic Bone Wax), Application (Neurosurgery, Orthopedic Surgery, Thoracic Surgery, Dental/Oral Surgery, Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027: https://www.databridgemarketresearch.com/reports/global-bone-wax-market

Global Vitamin D Therapy Market By Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027: https://www.databridgemarketresearch.com/reports/global-vitamin-d-therapy-market

Global Sickle Cell Disease Market, By Type (Sickle Cell Anemia, Sickle Hemoglobin- C Disease, Sickle Beta-Plus Thalassemia, Sickle Hemoglobin-D Disease, Sickle Hemoglobin-O Disease, Others), Diagnosis (Screening Tests, New-born Screening, Prenatal Screening, Others), Complications Type (Stroke, Acute Chest Syndrome, Pulmonary Hypertension, Organ Damage, Others), Treatment Type (Medication, Blood Transfusion, Bone Marrow Transplantation, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029: https://www.databridgemarketresearch.com/reports/global-sickle-cell-disease-market

Sopan Gedam
Data Bridge Market Research
+1 888-387-2818
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.